Effects of an aqueous extract of Crataegus pinnatifida Bge. var. major N.E.Br. fruit on experimental atherosclerosis in rats

Journal of Ethnopharmacology

Volumn 148, Issue 2, 2013, Pages 563-569

  Zhang, Jianyong ^a   Liang, Rixin ^a   Wang, Lan ^a   Yan, Renyi ^a   Hou, Rui ^a   Gao, Shuangrong ^a   Yang, Bin ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

Crataegus pinnatifida Bge. var. major N.E.Br. Aqueous extract Atherosclerosis Lipid lowering Anti inflammation Endothelial protection

Indexed keywords

6 KETO PROSTAGLANDIN F ALPHA; ANTILIPEMIC AGENT; C REACTIVE PROTEIN; CARDIOVASCULAR AGENT; COLECALCIFEROL; CRATAEGUS PINNATIFIDA EXTRACT; ENDOTHELIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 18; INTERLEUKIN 1BETA; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC OXIDE; OVALBUMIN; PLANT EXTRACT; SIMVASTATIN; THROMBOXANE B2; UNCLASSIFIED DRUG; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; BLOOD LEVEL; CONTROLLED STUDY; CRATAEGUS PINNATIFIDA; DRUG ISOLATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FRUIT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; HYPERLIPIDEMIA; LIPID DIET; MALE; NONHUMAN; RADIOIMMUNOASSAY; RAT;

6-KETOPROSTAGLANDIN F1 ALPHA; ANIMALS; ATHEROSCLEROSIS; BIFLAVONOIDS; C-REACTIVE PROTEIN; CATECHIN; CHLOROGENIC ACID; CRATAEGUS; DIET, HIGH-FAT; DRUGS, CHINESE HERBAL; ENDOTHELINS; FRUIT; INTERLEUKINS; LIPIDS; MALE; NITRIC OXIDE; PLANT EXTRACTS; PROANTHOCYANIDINS; QUERCETIN; RANDOM ALLOCATION; RATS; RATS, WISTAR; RUTIN; THROMBOXANE B2; WATER;

CRATAEGUS; CRATAEGUS PINNATIFIDA; RATTUS;

EID: 84879419439     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2013.04.053     Document Type: Article

References (31)

1. J. Beltowski, G. Wójcicka, and A. Jamroz-Wiśniewska Adverse effects of statins-mechanisms and consequences Current Drug Safety 4 2009 209 228
2. V. Braunersreuther, F. Mach, and S. Steffens The specific role of chemokines in atherosclerosis Thrombosis and Haemostasis 97 2007 714 721
3. ® 1442 targets the cAMP/Rap1 pathway Journal of Molecular and Cellular Cardiology 52 2012 196 205
4. Q. Cai, B.Y. Li, H.Q. Gao, J.H. Zhang, J.F. Wang, F. Yu, M. Yin, and Z. Zhang Grape seed procyanidin B2 inhibits human aortic smooth muscle cell proliferation and migration induced by advanced glycation end products Bioscience, Biotechnology, and Biochemistry 75 2011 1692 1697
5. J. Chen, B. Xue, K. Li, J. Shi, D. Krempin, M. Zhu, and C. Garland The effect of an instant haw beverage on lipid levels, antioxidant enzyme and immune function in hyperlipidemia patients Zhonghua Yu Fang Yi Xue Za Zhi (Chin) 36 2002 172 175
6. K.Y. Chyu, A. Peter, and P.K. Shah Progress in HDL-based therapies for atherosclerosis Current Atherosclerosis Reports 13 2011 405 412
7. S. Dahmer, and E. Scott Health effects of hawthorn American Family Physician 81 2010 465 468
8. J. Davignon, and P. Ganz Role of endothelial dysfunction in atherosclerosis Circulation 109 1 2004 III27 III32
9. P. Duewell, H. Kono, K.J. Rayner, C.M. Sirois, G. Vladimer, F.G. Bauernfeind, G.S. Abela, L. Franchi, G. Nuñez, M. Schnurr, T. Espevik, E. Lien, K.A. Fitzgerald, K.L. Rock, K.J. Moore, S.D. Wright, V. Hornung, and E. Latz NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals Nature 464 2010 1357 1361
10. M. Félétou, and P.M. Vanhoutte Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture) American Journal of Physiology-Heart and Circulatory Physiology 3 2006 H985 H1002
11. P.K. Hing Ling, F. Civeira, A.G. Dan, M.E. Hanson, R. Massaad, B. De Tilleghem Cle, C. Milardo, and J. Triscari Ezetimibe/simvastatin 10/40 mg versus atorvastatin 40 mg in high cardiovascular risk patients with primary hypercholesterolemia: a randomized, double-blind, active-controlled, multicenter study Lipids in Health and Disease 11 2012 8pp
12. T. Jurikova, J. Sochor, O. Rop, J. Mlcek, S. Balla, L. Szekeres, V. Adam, and R. Kizek Polyphenolic profile and biological activity of Chinese hawthorn (Crataegus pinnatifida Bunge) fruits Molecules 17 2012 14490 14509
13. E.S. Kao, C.J. Wang, W.L. Lin, Y.F. Yin, C.P. Wang, and T.H. Tseng Anti-inflammatory potential of flavonoid contents from dried fruit of Crataegus pinnatifida in vitro and in vivo Journal of Agricultural and Food Chemistry 53 2005 430 436
14. D.H. Kuo, C.H. Yeh, P.C. Shieh, K.C. Cheng, F.A. Chen, and J.T. Cheng Effect of shanzha, a Chinese herbal product, on obesity and dyslipidemia in hamsters receiving high-fat diet Journal of Ethnopharmacology 124 2009 544 550
15. J. Li, C.X. Chen, and Y.H. Shen Effects of total glucosides from paeony (Paeonia lactiflora Pall) roots on experimental atherosclerosis in rats Journal of Ethnopharmacology 135 2011 469 475
16. P. Libby, P.M. Ridker, and G.K. Hansson Progress and challenges in translating the biology of atherosclerosis Nature 473 2011 317 325
17. G.J. Liu, H.Y. Zhang, H.Q. Gao, L.H. Wu, Q.S. Wang, W.Y. Zhan, X.H. Yang, X.M. Lu, H.M. Zuo, and M.Y. Kang Effects of hawthorn fruit on hyper homocysteinemia in patients with coronary artery disease Chinese Journal of Pathophysiology (Chin) 18 2002 1332 1348
18. G.S. Liu, L. Li, Y.G. Duan, L. Wang, W.M. Zhang, and S.S. Hao Effects of hawthorn extracts isolated by different polar solvent on blood fat and hemorheological indexes in rats with hyperlipidemia Anhui Zhong Yi Xue Yuan Xue Bao (Chin) 27 2008 38 40
19. Y. Luo, G. Chen, B. Li, B. Ji, Z. Xiao, G. Yi, and F. Tian Dietary Intervention with AHP, a functional formula diet, improves both serum and hepatic lipids profile in dyslipidemia mice Journal of Food Science 74 2009 H189 H195
20. M. Nishida, T. Moriyama, K. Ishii, S. Takashima, K. Yoshizaki, Y. Sugita, and T.K. Yamauchi Effects of IL-6, adiponectin, CRP and metabolic syndrome on subclinical atherosclerosis Clinica Chimica Acta 384 2007 99 104
21. T.A. Pearson, G.A. Mensah, R.W. Alexander, J.L. Anderson, R.O. Cannon 3rd, M. Criqui, Y.Y. Fadl, S.P. Fortmann, Y. Hong, G.L. Myers, N. Rifai, S.C. Smith Jr., K. Taubert, R.P. Tracy, and F. Vinicor Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association Circulation 107 2003 499 511
22. J.M. Rigelsky, and B.V. Sweet Hawthorn: pharmacology and therapeutic uses American Journal of Health-System Pharmacy 59 2002 417 422
23. R. Ross Atherosclerosis-an inflammatory disease New England Journal of Medicine 340 1999 115 126
24. V. Singh, R.L. Tiwari, M. Dikshit, and M.K. Barthwal Models to study atherosclerosis: a mechanistic insight Current Vascular Pharmacology 7 2009 75 109
25. L. Wang, C. Geng, L. Jiang, D. Gong, D. Liu, H. Yoshimura, and L. Zhong The anti-atherosclerotic effect of olive leaf extract is related to suppressed inflammatory response in rabbits with experimental atherosclerosis European Journal of Nutrition 47 2008 235 243
26. W. Wang, B. Yang, L. Wang, R. Liang, C. Chen, N. Hu, L. Cheng, Y. Yang, X. Yin, S. Gao, and J. Ye Antiatherogenic effect of Radix Salviae Miltiorrhizae and Fructus crataegi on experimental atherosclerosis in rats Zhongguo Zhong Yao Za Zhi (Chin) 36 2011 784 789
27. Y.S. Wang, R.T. Lin, H.Y. Cheng, S.F. Yang, W.W. Chou, and S.H. Juo Anti-atherogenic effect of San-Huang-Xie-Xin-Tang, a traditional Chinese medicine, in cultured human aortic smooth muscle cells Journal of Ethnopharmacology 133 2011 442 447
28. C. Weber, and H. Noels Atherosclerosis: current pathogenesis and therapeutic options Nature Medicine 17 2011 1410 1422
29. J.A. Welsh, A. Sharma, J.L. Abramson, V. Vaccarino, C. Gillespie, and M.B. Vos Caloric sweetener consumption and dyslipidemia among US adults Journal of the American Medical Association 303 2010 1490 1497
30. B. Yang, and P. Liu Composition and health effects of phenolic compounds in hawthorn (Crataegus spp.) of different origins Journal of the Science of Food and Agriculture 92 2012 1578 1590
31. H. Zhang, C. Zhang, Y. Wang, M. Zhang, X. Jin, and P. Hu Qualitative and quantitative analysis of flavonoids in Chinese hawthorn fruit Zhongguo Zhong Yao Za Zhi (Chin) 37 2012 601 605 New Drugs Innovation